Biohaven Pharmaceutical Holding Co Ltd.·4

Jan 7, 9:17 PM ET

Engelhart James 4

4 · Biohaven Pharmaceutical Holding Co Ltd. · Filed Jan 7, 2022

Insider Transaction Report

Form 4
Period: 2022-01-06
Engelhart James
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Shares

    2022-01-06+3,75015,234 total
  • Exercise/Conversion

    Common Shares

    2022-01-07+3,25016,952 total
  • Tax Payment

    Common Shares

    2022-01-07$128.87/sh1,279$164,82515,673 total
  • Award

    Employee Stock Option (Right to Buy)

    2022-01-07+26,00026,000 total
    Exercise: $128.87Exp: 2032-01-07Common Shares (26,000 underlying)
  • Exercise/Conversion

    Restricted Share Unit Award

    2022-01-073,2509,750 total
    Common Shares (3,250 underlying)
  • Tax Payment

    Common Shares

    2022-01-06$123.86/sh1,532$189,75413,702 total
  • Exercise/Conversion

    Restricted Share Unit Award

    2022-01-063,7507,500 total
    Common Shares (3,750 underlying)
  • Award

    Restricted Share Unit Award

    2022-01-07+13,00013,000 total
    Common Shares (13,000 underlying)
Footnotes (7)
  • [F1]This balance includes 288 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2021.
  • [F2]No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
  • [F3]Each restricted share unit represents the contingent right to receive one common share of the Issuer.
  • [F4]The reporting person was granted 15,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date.
  • [F5]Not applicable.
  • [F6]The shares underlying this option vest in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service with the Issuer at each vesting date.
  • [F7]The reporting person was granted 13,000 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT